{
    "clinical_study": {
        "@rank": "139391", 
        "arm_group": [
            {
                "arm_group_label": "Narrow Gastric Conduit", 
                "arm_group_type": "Experimental", 
                "description": "The group in which narrowed gastric conduit will be performed during minimally invasive esophagectomy"
            }, 
            {
                "arm_group_label": "Wide Gastric Conduit", 
                "arm_group_type": "Experimental", 
                "description": "The group in which widened gastric conduit will be performed during minimally invasive esophagectomy"
            }
        ], 
        "brief_summary": {
            "textblock": "The study hypothesized that a narrow gastric conduit(less than 3cm in width) would minimize\n      anastomotic leakage following minimally invasive esophagectomy. Therefore we raise this\n      random-controlled research, and investigate the leakage ratio from different widths of\n      gastric conduit formed during the operation."
        }, 
        "brief_title": "The Optimal Width of Gastric Conduit for Minimally Invasive Esophagectomy: Wide or Narrow?", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Anastomotic Leakage", 
        "condition_browse": {
            "mesh_term": "Anastomotic Leak"
        }, 
        "detailed_description": {
            "textblock": "Patients underwent minimally invasive esophagectomy in Zhongshan Hospital of Fudan\n      University will be enrolled and be assigned to wide or narrow gastric conduit group\n      randomly. Intra-operative blood supply and vascular SaO2 will be observed during the\n      operation, and the rate of anastomotic leakage, together with its clinical details will be\n      recorded in the two groups."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patients underwent minimally invasive esophagectomy(three-hole procedure)\n\n          2. Clinical Staged T1-3N0M0 esophageal cancer patients or: patients who were restaged as\n             T1-3N0M0 esophageal cancer after neo-adjuvant therapy\n\n        Exclusion Criteria:\n\n          1. With previous cancer history\n\n          2. Severe Co-morbidity"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 22, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01696682", 
            "org_study_id": "ZSchest2012001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Narrow Gastric Conduit", 
                "description": "The gastric conduit will be formed much narrower in the intervention arm during minimally invasive esophagectomy", 
                "intervention_name": "Narrowed Gastric Conduit", 
                "intervention_type": "Procedure", 
                "other_name": "Narrowed Gastric Tube"
            }, 
            {
                "arm_group_label": "Wide Gastric Conduit", 
                "description": "A widened gastric tube will be formed during the surgery", 
                "intervention_name": "Widened Gastric Conduit", 
                "intervention_type": "Procedure", 
                "other_name": "Wide Gastric Tube"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "minimally invasive esophagectomy", 
            "anastomotic leakage", 
            "gastric conduit"
        ], 
        "lastchanged_date": "February 7, 2013", 
        "location": {
            "contact": {
                "email": "shen.yaxing@zs-hospital.sh.cn", 
                "last_name": "Yaxing Shen, MD", 
                "phone": "86-13661983366"
            }, 
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "zip": "200032"
                }, 
                "name": "Division of Thoracic Surgery, Zhongshan Hospital of Fudan University"
            }, 
            "investigator": {
                "last_name": "Hao Wang, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Study on the Difference of Anastomotic Leakage Ratio Between Wide and Narrow Gastric Conduit During Minimally Invasive Esophagectomy", 
        "overall_contact": {
            "email": "SHEN.YAXING@ZS-HOSPITAL.SH.CN", 
            "last_name": "Yaxing Shen, MD", 
            "phone": "86-13661983366"
        }, 
        "overall_official": {
            "affiliation": "Fudan University", 
            "last_name": "Lijie Tan, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The anastomotic leakage is a severe complication following minimally invasive esophagectomy. The definition of anastomotic leakage is determined as per the STS (SOCIETY OF THORACIC SURGEONS) database.", 
            "measure": "The anastomotic leakage rate", 
            "safety_issue": "Yes", 
            "time_frame": "the anastomotic leakage of participants will be followed for the duration of hospital stay, an expected average of 2 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01696682"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Fudan University", 
            "investigator_full_name": "Tan, Lijie", 
            "investigator_title": "Associate Professor of Surgery; Vice Chief, Division of Thoracic Surgery", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Fudan University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fudan University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}